Conavi Medical Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023
Revenue	0.71	9.12	2.16	24.65	24.65
Revenue Growth (YoY)	-92.66%	322.12%	-91.23%	-	-
Cost of Revenue	-0.05	1.5	2.11	-	-
Gross Profit	0.76	7.63	0.05	24.65	24.65
Selling, General & Admin	5.23	6.15	7.07	11.96	11.96
Depreciation & Amortization Expenses	0.79	0.81	0.99	-	-
Research & Development	9.43	15.27	17.94	4.49	4.49
Other Operating Expenses	0.36	5.24	0.29	-	-
Total Operating Expenses	15.81	27.47	26.29	16.45	16.45
Operating Income	-15.05	-19.84	-26.23	8.21	8.21
Total Non-Operating Income (Expense)	-5.48	10.84	9.3	-0.51	-0.51
Pretax Income	-20.52	-9	-16.93	7.7	7.7
Net Income	-20.52	-9	-16.93	7.7	7.7
Net Income to Common	-20.52	-9	-16.93	7.7	7.7
Shares Outstanding (Basic)	97	58	6	4	4
Shares Outstanding (Diluted)	97	58	6	5	5
Shares Change (YoY)	650.07%	833.52%	25.30%	-	-
EPS (Basic)	-0.71	-0.36	-7.08	0.06	4.98
EPS (Diluted)	-0.71	-0.36	-7.08	0.06	4.59
EPS Growth	-	-	-	-98.69%	-
Shares Outstanding	76.75	76.75	-	-	-
Free Cash Flow	-20.7	-25.17	-20.72	2.38	2.38
Free Cash Flow Per Share	-0.21	-0.44	-3.36	0.48	0.48
Gross Margin	107.51%	83.61%	2.45%	100.00%	100.00%
Operating Margin	-2131.16%	-217.49%	-1213.93%	33.29%	33.29%
Profit Margin	-2907.08%	-98.68%	-783.43%	31.22%	31.22%
FCF Margin	-2931.44%	-275.96%	-958.95%	9.65%	9.65%
EBITDA	-14.33	-19.33	-25.71	8.49	8.49
EBITDA Margin	-2029.60%	-211.93%	-1189.59%	34.42%	34.42%
EBIT	-15.05	-19.84	-26.23	8.21	8.21
EBIT Margin	-2131.16%	-217.49%	-1213.93%	33.29%	33.29%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.